Jeffrey Robert Ajer, EVP, Chief Commercial Officer: Biomarin Pharmaceutical BMRN Sell · Filed 23/01/27

Trade details

Type: Insider sale
Amount: $5,184,011.25
Shares · price: 44,825 sh · $115.65 a share
Held after: 45,263 sh
Stock: Biomarin Pharmaceutical BMRN
Person: Jeffrey Robert AjerEVP, Chief Commercial Officer
Trade date: 23/01/25
Filed: 23/01/27
Days to filing: 2 days

Sold 49.8% of holdings

Share of holding sold: 49.8%

Biomarin Pharmaceutical trades, last 26 weeks

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 22/12/26~23/02/24

Jeffrey Robert Ajer's recent trades

Jeffrey Robert AjerEVP, Chief Commercial Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$414.6K
5,000 sh
$414.6K
Filed 24/05/06
Traded 24/05/02
Jeffrey Robert AjerEVP, Chief Commercial Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$348.3K
4,000 sh
$348.3K
Filed 24/03/07
Traded 24/03/05
Jeffrey Robert AjerDirector
SellNektar Therapeutics
Sell
Nektar Therapeutics
NKTR
$3,008
4,359 sh
$3,008
Filed 23/09/20
Traded 23/09/18
Jeffrey Robert AjerEVP, Chief Commercial Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$450K
5,000 sh
$450K
Filed 23/08/17
Traded 23/08/16
Jeffrey Robert AjerEVP, Chief Commercial Officer
SellBiomarin Pharmaceutical
Sell
Biomarin Pharmaceutical
BMRN
$484.9K
4,175 sh
$484.9K
Filed 23/01/27
Traded 23/01/25

Jeffrey Robert Ajer, Chief Officer — sold $5.2M of Biomarin Pharmaceutical BMRN · 49.8% of holdings | Whalegun